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Quotation
Who can unlearn all the facts that I've learned? I sal in their chairs and my synapses
burned. The torture of chalk dust collects on my tongue. Thoughts follow my vision and
dance in the sun . While my vasoconstrictors they come slowly undone. Can 't this wait
till I'm old, can't I live while I'm young?

-Trey Anastasio
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Abstract:
The synthesis of both cis and rrans-RuCIJDMSO)J has been reported in literature,
and is currently the only way of acquiring these compounds. Because these rnetallo
drugs have shown similar antirumor properties to cisplatin, they are currently under
investigation for use in clinical trials as potential chemotherapeutics. It is believed that
these drugs act in a way similar to cisplatin by causing intrastrand crosslinking of
adjacent guanine residues in DNA. In an auempt to better understand any RulDNA
interaction for these compounds, both cis and rrans-RuCl 2(DMSO)J were synthesized
with reasonable yields (-40%). The compounds were then characterized by nuclear
magnetic resonance (NMR), combustion elemental analysis (CHN), and ultraviolet
visible spectroscopy (UV -Vis). These compounds were then reacted in aqueous solution
with various types of DNA (calf thymus, nucleosides, and a synthetic 11 base
oligonucleotide). The products of these reactions were separated and collected using
either two different types of high performance liquid chromatography (HPLC), ethanol
precipitation, or centrifugation filtration. Collected products were then analyzed using
inductively coupled plasma atomic emission spectroscopy (lCP-AES) and electrospray
ionization mass spectrometry (ESI-MS). Reactions with calf thymus DNA proved very
hard to work with and only allowed for some indications of the reaction kinetics. Focus
was then directed towards nucleosides and the II base oligonucleotide. No Ru-bound
DNA was seen using ESI-MS , but the HPLC traces did indicate some RulDNA
interaction. HPLC data suggested that this interaction may be reversible over time. The
solution chemistry of

me compounds was examined and compared to previous reports.

It

was discovered that the presence of phosphate buffer in solution with cis'-RuCI2(DMSO)J
causes the formation of a ruthenium/phosphate dimer of proposed molecular formula
Ru 2POiDMSOMH 20 )x. If this dimer is formed inside cells, it may be partially
responsible for the lower antitumor activity of cis-Ru0 2(DMSO)J compared to trans
RuCl,(DMSO)4'
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Introduction

For many years heavy metal compounds have been used in medicine for the
treatment of multiple types of diseases and disorders. These compounds range in their
applications from physical ailments such as arthritis, to life saving effects in the treatment
of canceL I Among the most widely used chemotherapeutic drugs are the platinum mew
compounds, and in particular cisplatin (Figure la).

H~~CI

H~'" ~Cl
Figure la- The structure of cisplatin, Chlorides are replaced by coordinated
water molecules when dissolved in aqueous solution.
Cisplatin is a square-planar molecule whose anticancer mechanism has been extensively
studied and is moderately well understood. l, 2 The mode of antitumor activity for
cisplatin is believed to involve covalent binding to DNA in the cell, destabilizing the
structure of DNA. This modified structure is recognized by DNA binding proteins in the
cell and is most likely responsible for cell death.3 It has been shown that the major DNA
binding site for cisplatin is the electron rich N7 position on guanine bases. The major
adduct of cisplatin on DNA is the intrastrand crossllnking of the N7 positions of adjacent
guanines (GpG) (Figure lb). This covalent binding significantly alters the B-DNA
backbone and can bend it by as much as 40°.1
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Figure Ib- The structure of cisplatin bound
guanines forming an intrastrand crosslink.

(Q

the N7 position of two adjacent

A variety of other platinum compounds have also been studied and are used for
the treatment of some types of cancer including lung, cervical, and ovarian carcinomas.
as well as acquired cisplatin resistant carcinomas and tumors . One such compound,
carboplatin (Figure 2), is a second-generation platinum chemotherapeutic being used
clinically. However, cisplatin and analogous compounds such as carboplatin have not
expanded to cover as broad an antitumor spectrum as was originally hoped.I- 2

IT

H'~O-~A

H,N. . . . . P~o--(""/
o
Figure 2- The structure of carboplatin. This drug is a second generation platinum
compound developed in the wake of the success of cisplatin.

The successes of platinum drugs have sparked an increasing interest in the
anticancer activity of other transition metal compounds, especially those located near
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platinum on the periodic table of elements. Among these are compounds containing Nb,
Mo, Fe, Sn, Ti, Rh, and in particular to this study, ruthenium (Ru). A variety of these
compounds do exhibit DNA binding and anticancer activity, but less is known about the
nature of their DNA-binding interactions and anticancer mechanisms compared to
platinum anticancer compounds. There is a sense among some scientists that too much of
the proposed mode of action for these drugs may be considered analogous to platinum
drugs without proper justification. 2
Studies as far back as 1975 were conducted on the antitumor properties of cis
dicholortetrakis (dimethyl sulfoxide) ruthenium (II) [RuCI 2(DMSO)4] (Figure 3a).

DMSOI111•

DMSO.....

9MSO

I .\\\\ CI

i~C,
DMSO

Figure 3a- The structure of cis-RuCliDMSO)4 ' Ru binds DMSO through the
lone pair electrons on either oxygen or sulfer. One axial DMSO group is oxygen
bound, while the remaining DMSO groups are sulfur bound.
These studies indicated that this Ru compound has very similar biological effects on
several different strains of E. coli. These biological activities included lambda induction,
filamentous growth production and selective toxicity towards a recA strain with DNA
repair deficiency. From over ten different metal compounds tested, only cisRuOlDMSO)4 showed comparable activity with cisplatin.f Upon further study of
different bacterial strains each containing the gene for a different repair mechanism, it
was shown that cisplatin and cls-Ru0 2(DMSO)4 exhibited selective activity towards
different strains. This suggests that the mechanism for
compounds is most likely different. 5

me antitumor activity of the two
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Due to the potential for cis-RuCliDMSO)J as a new antitumor drug, many efforts
were made to study its behavior and some interest was placed on similar Ru compounds.
Indeed many new Ru-DMSO compounds were developed to test for antitumor activity.I'

It was later discovered that trans-RuCliDMSO)J (Figure 3b) also showed anticancer
activity and at a similar level to cisplatin when administered at equitoxic dosages.?

'f'

HJ)~CH,
DMSO

DMSO,/,•.

r,,~DMSO

DMSO~'~DMSO
CI

Figure 3b- The structure of trans-RuC!2(DMSO)J. All DMSO groups are sulfur
bound.
The effects of cis-RuCI2(DMSO)J and lTOns-RuCI 2(DMSO)J differ from cisplatin
on cancer cells. CispJatin is very effective in reducing the size of primary tumors, while
both Ru compounds show an almost inability to affect primary tumors in mice. These
ruthenium compounds, however, are able to reduce the size and number of lung
metastases, on which cisplatin has little or no effect. What is more intriguing about these
compounds is their ability to prolong mice lifetimes by a significant amount after surgical
removal of the primary tumor, another application unfulfilled by cispJatin. 8 TransRuCI 2(DMSO)J is shown to be slightly more effecti ve in all areas of activity than cisRuCllDMSO)J when administered at equitoxic dosages. Trans-RuC12(DMSO)4 is much
more toxic at equimolar concentrations, but has high enough activity that it can be
administered in much smaller quantity.8
The toxicity of meL11 drugs in the body is often caused by metal binding to
nucleophilic nitrogen and sulfur atoms on proteins involved in metabolism. When the
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concentration of these metals becomes too high, cellular metabolism is affected and the
selecti vity for tumor cell death is lost. Different metallo-drugs have different lOX icity
levels depending on their own susceptibility to these protein nucleophiles. 3 Some protein
binding may be beneficial however. It has been shown that a Ru-indazole complex
(Figure 3c) reversibly binds to the His253 position of the iron transport protein
apolactoferrin. This binding is believed to be a delivery mechanism for this compound to
Ulmar cells which are rapidly dividing and are in need of large amounts of iron.!

Figure 3c- The structure of a Ru-indazole complex which has shown cell delivery
through transport protein binding as opposed to the passive membrane transport
suggested for cis and trans-RuCI2(D M SO )<\ .
The behavior of both cis and

lrans-RuCliDMSO)~

in aqueous solution is well

known . Although they behave differently, it has been proposed that the mechanism for
cell entry by both is the passive transport of a neutral species across the cell membrane.
Once inside the cell where chloride concentrations are lower, a chloride is thought to be
displaced, providing a labile H20 coordination for DNA-binding of the charged species.f

In solution, ITans-RuC1 2 (D M SO )4 very rapidly loses two dimethyl sulfoxide groups,
followed by a much slower loss of a single chloride. Cis-RuCliDMSO)4 rapidly loses
one dimethyl sulfoxide and more slowly a single chloride. All dissociated ligands are
replaced by H20 coordination.f Although the behavior of these species in water is
thought to be well understood (Figure 4), their interaction with DNA is still somewhat
indeterminate, despite all of the studies that have been conducted .
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Among the first studies conducted to determine the nature of the interaction
between DNA and these Ru compounds was the reaction of calf thymus DNA (CT-DNA)
as well as poly(dAdD and poly(dGdC) with cis-RuCl2(DMSO)4 ' The reactions were
monitored by ultraviolet-visible spectroscopy (UV -Vis) . An undetermined reaction
product was seen for the reaction with CT -DN A and it was suggested that the reactions

with poly(dAdD and poly(dGdC) indicated binding at the N7 position of both purines,
but the data was not conclusive.9 Other CT-DNA studies monitored by UV-Vis, done in
I mM phosphate buffer (pH=7) and 3 roM sodium chloride (NaCl) to mimic cellular
conditions, showed that the rate for DNA binding of rrans-RuCI 2(DMSO)4 was markedly
higher than cis-RuCliDMSO)4. 8 This was the ftrst insight into a possible explanation for
the higher activity of l7ans-RuCl 2(DMSOL in vivo, although it was not conclusive as to
the mechanism of action.
Focus was then moved towards nuclear magnetic resonance (NMR) as an
analytical tool for the characterization of the reactions between cis or trans
RuCI,(DMSO)4 and DNA. NMR results for reactions with either 5' -GMP or 5' -AMP
showed conclusively that cis-RuCI 2(DMSO)4 is coordinated via the N7 position of
guanine, and that there is weaker interaction with rhe phosphate monoester. Intrastrand
crosslinking for these ruthenium compounds similar to that of cisplatin would require a
that a single Ru could bind to the N7 position of two separate DN A bases. The binding
in this study was in a 1:1 ratio; the predicted bisadduct was not observed. There was no
conclusive proof of any interaction between cis-RuCllDMSO)J and the N7 position of
adenine. lO Because ruthen ium coordination with the phosphate group on 5' -GMP may
be much stronger

man with the phosphodiester linkage of DNA strands, 2' -dG was
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chosen as a more realistic model for ruthenium-DN A binding in the cell . NMR data
taken on the interaction between trans-Ru0 2(DMSO)4 and 2' -dG showed the formation

of two monoadducts (Ru-2' -dG) and one bisadduct (Ru-(2' -dG)2) all of which were
reversible . It was suggested that the relatively low toxicity versus activity of trans
RuCllDMSO)J compared

to

cisplatin may be due to the reversibility of these bonds, and

that the formation of a bisadduct may account for antitumor activity. 1I An even better
model than either 5' -GMP or 2' -dO for NMR characterization was thought to be d(GpG) .
Again the interaction of trans-RuCliDMSO)J compound was examined, as it is the more
likely candidate for pharmaceutical use due to higher activity. It was determined thai a
1,2 intrastrand crosslink was formed which altered the conformation of the dimer in a
manner similar to the binding of cisplatin to DNA. A similar structure alteration was
seen when rrans-RuCliDMSO)4 was reacted with d(TpGpGpT), indicating that this
binding and structural change may be applicable to larger strands and to DNA itself. 12
These models provided insight into possible mechanisms, but they are barely
comparable

to

cellular DNA, and they are still lacking an explanation for differences and

similarities in the anticancer activity of cis and lrans-RuCL,lDMSO)4' Later studies
attempted

LO

examine Ru interactions with larger strands of DNA and to compare

reactions of both cis and trans-RuCliDMSO)4' NMR data for both cis and trans
RuClz(DMSO)4 reactions with ApG, GpA, d(ApG), and d(GpA) showed one major
product and mulitple minor products. This presence of multiple minor products is
different from the reaction of /rans-RuCliDMSO)4 with d(GpG) which gave only the
bisadduct and its intermediates. In this study there was conclusive evidence that both
compounds bind to adenine via the N7 position.l 3 A quantitative study showed the

16
reaction rate of rrans-RuOlDMSO)4 to be 20 times that of cis-RuCI 2(DMSO)4' The
reaction of trans-RuCl 2(DMSO)4 with the oligomer d(CcrGGTCC) also gave more than
one product, and gave no conclusive results indicating Ru-(G-N7)2 formation. The
kinetics study indicates that the lower activity of cis-RuCl 2(DMSO).j could be due to its
slower reaction with DNA. This study also suggests that perhaps d(GpG) data is not an
appropriate model for cellular DNA in these studies, and that the mechanism for
ruthenium anticancer activity is perhaps different from that of cisplatin . It may involve
disrupting duplex DNA hydrogen bonding by coordination to N7 on adenine, which
affects the acidity of protons within the base. 13
More recently the use of electro-spray ionization mass spectrometry (ESI-MS) has
been used to study these compounds. ESI-MS gives molecular masses, but can have
problems with ligand loss in the spray source. Using ESI-MS as an analytical tool, the
reaction of equimolar amounts of cis and trans-RuCl 2(DMSO)J with 2' -dG reportedly
gave identical product formation for each. Mass spectrum peaks were attributed to one or
rwo 2' -dGs bound to a RuCllDMSOh moiety with undetermined stereochemistry. For a
reaction between 2' -dA and trans-Ru0 2(DMSO)j, the bound Ru complex was again
RuCI 2(DMSOh, but the cis-RuCI2(DMSO)J reaction product also contained
RuCliDMSOh This difference in the binding to 2' -dA suggests that coordination of
adenosine in vivo may be the cause of the differences between cis and transRuC12(DMSO)J' and the basis for their activity.I'l ESI-MS was also used to analyze the
reaction of cis and trans-RuCJ 2(DMSO)4 with the oligomer d(GGCTAGCC) in
anunonium acetate (NH 40Ac) at pH::=6.8. The results indicated that the same products
were formed in each reaction, but in varying amounts. The Ru-bound oligomer products
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ranged from Ru-oligorner only

(0

RuCIlDMSO)J-oligomer, and all mass combinations

in between. There was no indication that two metals bound to one oligomer at the same
time, and all binding was reversible. Product decomposition was observed within six
days for each product. 15
With all of the work that has been done in an anempt to understand the action of
these potential drugs, there is still very little known conclusively about their mechanism
for antitumor activity inside the cell. A deta..iled understanding of the mechanism of these
drugs, coupled with existing knowledge about cisplatin may allow for the design of more
effective drugs in the fight against cancer. It was the purpose of this experiment to
synthesize both cis and Irans-RuCl 2(DMSO)4 in order to react them with various types of
DNA in hopes of isolating and structurally characterizing a Ru-DNA adduct.
The synthesis followed as closely as possible the literature protocols for the
synthesis of cis-RuCllDMSO)J 16 and its photochemical conversion to trans
RuCI 2(DMSO)4 7. DNA reactions were done with nucleosides, CT-DNA, single-stranded
and duplex forms of an t l -base oligomer:

5' - GCTTGGTATCG - 3'

Strand 1

3' - CGAACCATAGC - 5' Strand 2
The significance of the l l-rner chosen is that the duplex contains every possible
combination of nucleotide dimers, as well as a GG dimer in the center of Strand 1. As
with previous studies, reaction conditions varied in time, both buffer and salt
concentrations, and the amount of time the Ru compounds had been dissolved in solution
before reactions were started. Most reactions were allowed to run for one week, but
samples were examined anywhere from the initial minutes to multiple weeks. Salt and
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phosphate buffer were used to mimic cellular conditions for some reactions . I( has been
reported that the presence of phosphate buffer can change the chemistry of both cis and
lrans-RuCI2(DMSO)~

in solution, and that some covalent interactions between Ru and

phosphate may possibly occur (Figure 5). These interactions may interfere with Ru-DNA
binding 8.
The synthetic products, both cis and

lrans-RuCl2(DMSO)~.

were analyzed using

NMR, combustion elemental analysis (CHN), and UV -Vis. Products from the reactions
between these compounds and DNA were analyzed using several different techniques.
UV-Vis was used

to

determine DN A concentrations. Inductively coupled plasma atomic

emission spectra (ICP-AES) was used to determine Ru concentrations. Two separate
types of high performance liquid chromatography (HPLC) were used

(0

monitor reactions

and also to separate reaction products and starting materials. Peaks collected by HPLC
that were thought to be products of Ru-DNA binding were examined using ESI-MS, in
hopes of finding peaks which could be attributed to Ru bound DNA.
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Materials and Methods

Synthesis of Metal Compounds: RuC1 3- XH 20 was purchased from So-em
Chemicals. Anhydrous dimethyl sulfoxide (DMSO), reaction grade acetone and ether
were purchased from Acros . Cis-RuCllDMSO)4 was synthesized according to
previously reported literature.1 6 The synthesis was performed on two separate
occasions. The first contained 1.002 g Ru0 3 ,XH 20 in 5 ml DMSO and was heated and
allowed to reflux for 5 min. A 50 mL portion of reaction grade acetone was added to
solution, which was left at -lOoe for 3 weeks . The supernatant was decanted and crystals
were washed with cold acetone/ether and then recrystallized in a minimum of hot DMSO,
with enough acetone added dropwise to cloud the solution, followed by enough hot
DMSO to make it clear again. The solution was allowed to coolon the bench top, the
yellow crystals were again washed, and then allowed to dry overnight in an oven at

100°C.
The second preparation of cis-RuCilDMSO)J contained 0.9995 g

RU0 3'X~O

in

5 mL DMSO and was again allowed to reflux for 5 min. The solution volume was then
reduced to half using a rotary evaporator with a vacuum pump. A 20 mL portion of
acetone was added, and precipitated crystals were isolated by decanting the supernatant.
The crystals were again washed with acetone/ether and recrystallized in the same manner.

Trans-RuCI 2(DMSO)J was synthesized according to previously reported
literature'? The photoreaction from cis to Trans-RuCilDMSO)J was performed using a
fan-cooled Rayonet Photochemical Reactor in a 25 mL quartz tube provided by professor
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Wayne Smith. The first of these reactions contained 0 .1033 g cis-RuC1 2(DMSO)4 in 3.2
mL DMSO (80°C) and was irradiated with ultraviolet light for 3 hr while being
monitored using a Hewlett Packard 8452A diode array spectrophotometer (UV-Vis). The
orange crystalline product was isolated by pipetting off the supernatant, and allowed to
dry on the bench top . The second reaction contained 0.0292 g cis-RuCIlDMSO).l in 1

mL DMSO (80°C) and was irradiated for 1.5 hr and again monitored by UV-Vis. The
solution volume was then reduced by rotary evaporation until precipitate was formed.
The supernatant was pipetted off and the orange crystals were allowed to dry on the
bench top. A large scale photoreaction was done containing 0.4082 g cis-RuCI 2(DMSOL
in 12.5 mL DMSO(800C). The mixture was irradiated for 3 hr and allowed to sit
overnight The orange crystal product was then vacuum filtered, washed with
DMSO/acetone and vacuum dried.
The reaction products were characterized for comparison to literature values7
using melting point values, an Exeter Analytical Inc. CE-440 Elemental Analyzer (CHN),
and a Broker Avarice 400 spectrometer (NMR). NMR spectra were done in either d6
DMSO or CDCl3 and both IH spectra of 128 scans at 400 MHz and 13C spectra of 1024
scans at 100 MHz were collected.

Nucleic Acid Preparation: Calf thymus DNA(CT DNA) was purchased from
Sigma. Solutions were taken from Kate Davies (Colby, 2000) old stocks, or made by
dissolving 15.3 g cr DNA in 10 mL 20 mM NaPi buffer(pH=6.9). The nucleosides 2'
deoxyguanosinetdfij-Xf-l.O, 2' deoxycytidinerdf'j-Ut.O, 2' deoxyadenosinerd.Aj-Xl-l.O,

and thyrnidinefT) were purchased from Aldrich, and dissolved in distilled H2 0 (dH 20 ).

2L
The 1 L-mer DNA strands supplied by Shari Dunham, were synthesized using
conventional phosphorarnidite methods on an ABI 391 DNA synthesizer and purified by
ion exchange chromatography on a Dionex DNApac column(PA-100, 9mm x 25mm) at 5
mUmio of NaCI gradient in 50 mM NH 40Ac (pH=6.9), 10% acetonitrile.

MetaUDNA Reaction Conditions: For reactions between

cr DNA and

the

metal compounds, the concentration of DNA base pairs was 2 mM, and Ru
concentrations varied from 200 J1,M to 2 roM Ru. Solutions were buffered with I mM Pi
buffer (pH=7) with 3 mM NaCl and were placed at 3rC in the dark. Timepoints were
taken and unbound Ru removed to stop the reaction by one of two methods. One method
involved increasing the NaCI concentration to 0.5 M, followed by ethanol precipitation of
the DNA l7 which was then redissolved in dH 20. The other separation technique
involved removal of unbound Ru through centrifugation filtration using Amicon
Centriprep concentrators with a molecular weight cutoff of 30,000 g/mol. Studies done
by Dr. Shari U. Dunham showed that five centrifugation cycles could reduce the Ru
concentration to a fraction of the inirial amount, Each cycle involved diluting the
timepoint up to 15 mL and spinning three times for IS, 10, and 5 minutes a13000 rpm in
a JA-lO rotor on a Beckman 12-21 centrifuge at 1592xg followed by removal of filtrate.
The firs 1 two dilutions contained 0.2 mM NaCl, and the final three dH 20 only.
The reactions between nucleosides and the metal compounds were performed in
dH 20 except for one reaction between cis-RuCI 2(DMSO)J and dG in 1 mM Pi buffer
(pH=7). Conditions ranged from 200 to 400

hlM DNA base pairs. with 1 roM Ru,

at
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3rc.

Reactions were monitored by reversed phase (RP) HPLC using Waters 50 1 pumps

with an automated gradient controller and a lambda-max 481 UV-Vis detector on a
Waters microbondapak C18 column with UV detection at A260 nm • Injection of the
reactions onto the HPLC column was used to stop the reactions and isolate products.
Reactions lime varied from hours to weeks.
Reactions of the Ll-rner duplex. strand I, or strand 2 with the metal complexes
were done al400 11M DNA base pairs, ImM Ru, and I mM Na.Pi buffer (pH=?) at 37°C.
Reactions were monitored using both RP and size exclusion (SE) HPLC. SE HPLC was
performed on a Shodex Ohpak SB-803HQ column with UV detection at A260 om.
Reactions time varied from hours to weeks for all metal-DNA reactions.

Quantltation of DNA: The concentration of DNA in solution was determined by
UV-Vis (A260nrn) 18. The instrument was blanked with a 1xTNE solution. Solutions
were diluted until absorbance readings were between 0.5 and 1 OD.

Quantitation of Bound Ru: Samples were diluted to a minimum volume of 1.5
2.0 rnl., with an expected Ru concentration of

00

less than 200 ppb, below which the

calibration of the instrument was sometimes less than ideal. Samples were then ruo on a
Leeman Labs PSlOOOUV Inductively Coupled Plasma Atomic Emissions Spectrometer
(lCP). The ICP was run with an argon coolant flow of 14 Umin, I kW of power, a
nebulizer pressure of 50 psi, and dH 20 used to rinse for 120 sec between samples.
Standards of O. 40, 120 480, 1000, and 2000 ppb Ru concentration were used to generate
calibrations curves. The multi-element standard solution (CLMS-3) used to generate
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calibration curves for the instrument was certified by Spex CertiPrep. For certain

cr

DNA reactions where irreversible DNA precipitation occurred, acid digestion of the
DNA sample followed by ICP was used to determine the concentration of DNA-bound
Ru. Trace metal grade nitric acid purchased from Fisher was used to make these
precipitated DNA solutions 33% nitric acid, which were then allowed to sit for four days.
Solutions were diluted from 1.5 to 5 mL with dH 20 and then analyzed for Ru using the

rep as described above.

Enzymatic Digestions: Alkaline phosphatase (AP), PI nuclease (PI ), and
deoxyribonuclease I (DNase) were purchased from Sigma. Five to six ug of DN A along
with 5 units DNase r and I unit PI in approximately 30

J.!L lxDI/P1 buffer (100

mM

NH 40Ac, 10 mM MgCl 2 , pH=5 .0) were incubated at 37°C for 1-3 hr. Thirty ul, of 2xAP
buffer (0.2 roM EDTA, 200 ruM Tris-HCI, pH=8.75) and I unit of AP were then added
and the solution was incubated for 1-1.5 hr. Digestions were analyzed by RP HPLC.

HFLC: High Performance Liquid Chromatography was used to monitor reaction
product formation and to collect the products of reactions and enzymatic digestions.
Injection volumes varied from 10 to 250 J..LL. Nucleoside and l I-mer reactions with Ru
were analyzed by RP HPLC on a Waters microbondapak. C18 column (serial
#p72181B47, PIN 27324, 3.9rnm x 300mm). Two separate gradients of buffers A and B
with constant flow of 1 mUmin were used depending on reaction conditions and can be

24
seen in Table I (Buffer A: 0.1 M NH 40Ac pH=4.5, Buffer B: 0.05 M NH 40Ac, 50%
MeCN pH=4.5).
Reactions between the l l-mer strands or the duplex with trans-RuC1 2(DMSO)J
were also analyzed using SE HPLC on a Shodex OHpak SB-803HQ column (serial #
6005073, 8mm x 300mrn, SE limit of I x 105 amu). A constant flow of 0 .5 mUmin of a
50 mM NaCI, 50 mM Na, Pi buffer (pH=?) was used to elute reaction products. For both
columns, products were recorded using UV detection at 260 nm.

ESI-MSIMS: Using direct infusion into the ion trap of an Agilent t 100 series
LClMS, reaction products collected by RP HPLC were analyzed by Electro Spray
Ionization Mass Spectrometry(ESI) for the presence of Ru-bound DNA. Samples were
introduced to the EST source at a flow rate of 600 ul/hr, via a kdScientific-100 syringe
pump. Spectra were acquired in both positive and negative ion mode with an average
skimmer potential of ±40 V. Normally the spectrometer scanned an average of 5 times
from mJz=lOO to 2200 at a rate of 13,000 mJz s', and the data were summed to give a
final mass spectrum. Samples obtained via SE HPLC could not be analyzed via ESI due
to the presence of high concentrations of nonvolatile Pi and NaCl in solution. These
compounds could cause buildup and clogging problems with the stainless steel low flow
needle used for most sample analyses. Such problems are not a concern for Buffers A
and B of me RP HPLC column, since they contain only volatile solutes.
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Results and Discussion

The protocol for the first synthesis of

cis-RuOiDMSO)~

differed from the

literature and from the second reaction due to the lack of an apparatus capable of
reducing the volume ofDMSO (bp 187°q.

For this reason 50 mL of acetone was added

instead of 20 mL to precipitate cis-RuCI 2(DMSO)4 out of solution. As there was no
immediate precipitation, the solution was kept in a freezer for three weeks . The cold
temperature helped to induce growth of large yellow crystals in the bottom of the flask.
After purification and oven drying were complete, the net result was 0.4594 g of cis
Ru0 2(DMSO)4 giving a net yield of 19%. The experimental melting point of 195°C is
very close to the literature value of 193°C. lH NMR spectra (Figure 6) showed four
singlets downfield of two singlets, corresponding to DMSO methyl prawns for four
different sulfur bound DMSO signals, one from free DMSO and one from oxygen bound
DMSO signal as was reported in the literature.16 The dissociation of the oxygen bound
DMSO group for some of the compound in solution is responsible for the free DMSO
signal. CHN data was within 1.1% of the predicted composition (Table 2), and UV-Vis
data also agreed with reported literature values giving peaks at 320 and 370 nm (Data not
shown). The second synthesis of cis-RuOlDMSO)4 followed the literature more closely
by partially reducing the volume of DMSO after refluxing using a rotary evaporator
connected to a vacuum pump. Upon addition of 20 mL of acetone, yellow cis
RuCl 2(DMSO)4 crystals fell out of solution instantly . Following the aforementioned
purification procedure and oven drying, 0.9222 g of compound was recovered. increasing
the yield of this reaction to 39%. The experimental melting point was equivalent to the
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literature at 193°C. NMR data was identical to that of the first reaction (Figure 7), and
the CHN data for this product was within 2.6% of the predicted composition (Table 2).
UV-Vis data was also consistent with reported values with peaks at 320 and 370 nm
(Data not shown). 16
Crystals from the first photoreaction from cis to trans-RuCI 2 (DMSO)4, irradiated
for three hours , were collected after one night of precipitation on the bench top. The
distinct change in the color of the crystals from yellow to orange was consistent with
reported photoreaction. IH NMR data (Figure 8) showed two methyl proton signals
consistent with the literature values of 2.62 and 3.38 ppm , and in the appropriate ratio of
1:3. The photoreaction was monitored by VV-Vis (Figure 9). The second small scale
photoreaction was placed in a rotary evaporator attached to a vacuum pump without
heating, in order to reduce the volume of DMSO. No heat was used during rotary
evaporation because it can cause the transition from "am back to cis-RuCliDMSO)4. 7
The resulting crystals, which precipitated overnight on the bench top. were also orange in
color. I H NMR data (Figure 10) was again consistent with the literature giving methyl
proton signals at 2.62 and 3.41 ppm. DC NMR data (Figure 1J) consisted of two carbon
signals at 43.02 and 41Alppm which are consistent with literature values.7 The UV-Vis
spectra of the final product in chloroform also agreed with the reported values of peaks at
300 and 440 nm and a shoulder at 340 nm (data not shown).7
The final photoreaction, performed on a large scale to produce enough trans
RuCllDMSO)4 for the desired DNA reactions, was irradiated for three hours . The
solution volume was again reduced using a rotary evaporator without heating, causing
precipitation to begin immediately. The solution was allowed to sit overnight to facilitate
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precipitation of more compound in order to maximize yield. The resulting orange
product was vacuum-filtered. washed with DMSO/acetone and vacuum-dried at room
temp. The final product mass of 0.1708 g corresponds to a 42% yield. CHN data was
within 1.2% of the predicted composition (Table 2). Both the ITGns-RuCllDMSO)4 and
remaining cis -Ru02(DMSO)4 compounds were placed in small glass viles wrapped in tin
foil, and stored at room temperature.
The initial reaction with DNA involved only cis-RuCIlDMSO)4' because the
production of the lrans-RuC!2(DMSO)4 was not yet complete. Reaction conditions were
intended to resemble cellular conditions. The concentration of cis-RuCllDMSO)4 was
1.5 roM with 1.5 mM base pairs of cr -DNA, I mM Pi buffer at pH 7. 3 mM NaCl, in a
37°C water bath in the dark. The 2 mL total volume was divided into ten 200 uL aliquots
which were collected over the course of the next four days. The reaction was stopped in
each of these timepoints by raising the chloride concentration to 0.5 M with concentrated
NaO. 9 The DNA was ethanol precipitated 17, and then redissolved in dH 20 and
prepared for DNA and Ru quantitation by UV-Vis and ICP analysis, respectively . The
first six timepoints of the control reaction containing no DNA were analyzed by ICP
determine the effective reduction of Ru in solution due

(0

(0

ethanol precipitation. It was

determined that the precipitation procedure reduced the concentration of Ru in solution
by at least 99.9% (Table 3). Upon quantitation of DNA in the precipitated react ion
timepoints, it was determined that the DNA in only the first two rirnepoints (at 0 and 3 hr)
had redissolved. Attempts were made to redissolve the remaining timepoints by heating
and vortexing, but were ineffective. Using ICP analysis, the Ru concentration in the first
two timepoints was then determined, and it was found that while the 0 hr timepoint
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contained only a fraction of the initial Ru concentration (within the margin left by
precipitation) the 3 hr timepoint contained more than 20% of the initial concentration of
ruthenium, the majority of which can be attributed to DNA binding.
The precipitation problem, which prevented analysis of almost all of the reaction
timepoints, was addressed in the next set of reactions by lowering the concentration of
metal in the reaction. The new ratio of DNA base pairs to metal would be 10: 1 rather
than the 1:1 ratio in the first reaction. The new concentrations were 2 mM CT-DNA and
200 uM Ru, again in 1 mM Pi at pH 7, 3 mM NaCI, and at 37°C in the dark. This
reaction was done for both cis and trans-RuC1 2 (D M SO)J' Timepoints were taken over
the next 75 hrs, using the same protocol as before to quench the reaction and remove
unbound Ru. The problem with DNA recovery and redissolving seen before was
corrected for cis-RuCllDMSO)J' with at least 80% recovery of all DNA. The same
problem seen with cis-RuC!2(DMSO)J in the first reaction, however, was now ocurring
with the trans-RuCl 2(DMSO)4 reaction timepoints. Only the first two tirnepoints (at 0
and 1 hr) showed enough dissol ved DNA in sol ution to be quantitated by UV -Vis.

Trans-RuCI2(D M SO)J is reported to have a kinetic rate of reaction with DNA of up to 20
times that of cis-RuCI2(DMSO)4' so it was not incredibly surprising that reducing the
concentration of Ru in the reaction just enough to accommodate analysis of cis
RuCI 2(DMSO)4 was not enough for trans-RuCliDMSO)4'
The cis-RuCI 2(DMSO)J timepoints were analyzed by ICP to determine the
amount of Ru bound for comparison with the recovered DNA concentration. The
insoluble frans-RuCI2(D M SO)4 timepoints were acid-digested with trace metal grade
nitric acid for four days. The digested samples were then analyzed by ICP to determine
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the percent Ru precipitated with DNA as compared to the original concentration of Ru in
the reactions. A binding curve plotting the data from both reactions was constructed
(Figure 12) and when compared to previous studies 8 the amount of Ru-DNA binding as a
function of time for both compounds was found to be similar to the reported values,
although there may have been significant error with a few of the cis-RuCI2(DMSO)4
timepoints. As reported, lrans-RuCI2(DMSO)4 showed much faster kinetics than cis
RuCI 2(DMSO)4'
A third and final reaction between

cr -DNA and the Ru compounds was

performed, but with a different separation technique used in an effort to eliminate the
irreversible precipitation of DNA for timepoints with significant amounts of Ru bound to
the DNA. Centrifugation filtration was used to remove unbound Ru. The chosen
reaction conditions reversed the concentrations of Ru and DN A to give 2 rnM cis or
LTans-RuCI 2(DMSO)J and 200 JlM

cr -DNA.

The DNA solution was in an Na, Pi buffer

solution at pH=7 which resulted in a reaction concentration of 6.6 mM Na, Pi. No NaG
was added. Reactions were placed in a shaking water bath at 37°C which did not allow
for the blockage of sunlight. Tirnepoints were collected and again the cis-RuC1 2(DMSO)J
reaction showed good recovery of DNA, but the DNA in most timepoints for the trans
RuCliDMSO).{ reaction precipitated out upon concentration with the centrifugation filter.
Rather than destroy any possible RulDNA adducts in the samples which had not
precipitated, in an effort to regenerate the kinetics curve for DNA binding created with
the last experiment, only certain samples which did not exhibit precipitation problems
were analyzed by ICP. It was determined that a small amount of Ru had bound in the cis
RuC12(DMSO)J 9 day timepoint, and possibly in the cis-RuCliDMSO)4 I day and trans
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RuCllDMSO)4 0 hr timepoints (Table 4). A portion of each of these samples was then
enzymatically digested and injected onto a RP HPLC column. If there were any RulDNA
interactions which could withstand the enzymatic digestion conditions, comparison of
these solutions to a control digestion solution might yield new peaks which could [hen be
isolated and studied further. The HPLC traces for digestion of tirnepoints cis
RuCllDMSO)4 I day and trans-RuOiDMSO)4 0 hr each contained one identical new

peak (Figure 13a). A large scale enzymatic digestion was performed on each timepoint
in January (three months later). The resulting traces showed the disappearance of the
previously seen nonstandard peak (Figure 13b). This may have been the result of the
disassociation of the RulDNA bond, which was reported to be reversible. I I
At this point the focus of the experiments was shifted away from CT-ON A due to
the precipitation problems it had presented. Attention was then redirected towards
reactions between cis or trans-RuCI 2(DMSO)4 and nucleosides. While this fonn of DNA
does not provide an ideal model of cellular conditions, it was hoped that it would prove
easier to work with and would provide Ru-bound DNA for further investigation.
initial reactions were done with trans-RuCI 2 (DMSO)4 and either dG or a
nucleoside mix (dG, dC, dA, T). These reactions contained no buffer which was typical
of previously reported reactions with nucleosides.l

l-

14 In the first of these reactions the

concentration of nucleosides was varied between 200 IlM and 400 11M while Ru
concentrations were held constant at 1 mM. For reactions with both dG and the
nucleoside mix, RP HPLC traces showed new peaks within 12 hours (Figure 14). Also,
for reactions with higher DNA concentration, each of these new peaks accounted for a
higher percentage of the total peak area of the HPLC trace. This suggests that the
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kinetics of the reaction producing these new peaks was dependent upon the concentration
of nucleosides . Because no changes were seen in the control DNA reactions, it was also
deduced that the new peaks could be attributed to some interaction between Ru and
DNA . The reactions were then repeated with only the higher DNA concentration
conditions, and the new peaks observed by HPLC were collected and stored in a freezer
for further study. The collections were to be observed at a later date by ESI-MS, and
could not be immediately analyzed because of delays in the availability of this
instrument.
Another experiment with nucIeosides was then performed, again between both Ru
compounds and dG as well as a nucleoside mix. As had been done in previous
experiments 19, initial reaction conditions consisted of either freshly dissolved Ru, or
"activated Ru compound", Ru which had been dissolved in solution and kept in the dark
for four days. If the behavior of both cis and trans- RuCI2(DMSO)~ in aqueous solution
played a role in their binding, or was responsible for the difference in their DNA-binding,
then the freshly dissolved and activated reactions should progress differently.
For all of these reactions many new peaks appeared on the HPLC traces which
were not seen for the control reactions of DNA or Ru alone . The reactions of both
activated cis and trans-RuCllDMSO)J with nucleosides gave nearly identical traces
(Figure IS-top), while the reactions of freshly dissolved cis-RuCliDMSO)4 and trans
RuOlDMSO).s were not the same (Figure 15-middle). The HPLC traces for both of the
freshly dissolved Ru reactions were also different from those of the activated Ru
reactions . All of these traces showed peaks not seen in either DNA or Ru controls(Figure
IS-top and bottom). This suggests a Ru-DNA interaction is occurring in each of these
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reactions. It also indicates that the DNA-binding of these compounds may be dependent
upon what stage of ligand dissociation the Ru is at when it comes in contact with DNA.
The new peaks seen in these HPLC traces were collected and stored in a freezer for ESJ
MS analysis.
The activation of these compounds by sol vation was repeated at a later date when
ESI-MS was available. and the solutions were analyzed for comparison to the reported
behavior of these molecules in aqueous solution. The mass spectrum for cisRuCllDMSO)4 (Figure 16a) agreed well with the reported species produced in solution.j
The spectrum for

Irans-RuCl 2(DMSO)~

(Figure 16b) however, showed some unexpected

peaks. Values of mlz attributed to species such as RuCl(DMSO)J(H 20 ) were observed,
which are not in accordance with the proposed order of ligand loss for trans
RuCI 2(DMSO)4 in water. Although only speculative, this data may suggest that the order
of ligand loss for this compound in water can differ from what was previously thought.
The last of the reactions with nucleosides was then done in phosphate buffer to
observe the effects of pH control and the presence of phosphate on these reactions. Cis
RuCI 2(DMSO)4 was reacted with dG alone. Many of the peaks previously seen on the
HPLC trace for this reaction without buffer were not seen for the buffered reaction, while
new sharper peaks did appear (Figure 17a). The presence of phosphate buffer in (he
reaction solution was men determined to have some affect on the DNA-binding
interaction of cis-RuCI 2(DMSO)4' assuming that these new peaks could be attributed to
an interaction between Ru and dG. The new peaks were again collected and stored in a
freezer. They were later run again under the same HPLC conditions and the peaks had
shi fred back to the retention time of dG alone "(Figure 17b). Upon availability of the
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instrument, these peaks as well as all of the peaks collected from the reactions between
these compounds and nucleosides were analyzed using ESI-MS. All samples showed
either no significant peaks or an rnIz attributed to nucleosides alone. This fact coupled
with the HPLC retention time change back to that of dG alone suggests that any Ru-DNA
interactions accountable for these peaks were reversible, a phenomenon previously
observed and reported in the literature for similar reactions. These results provide only
an indication that a Ru-DNA interaction occurred which may have been observable had
the reaction products been immediately analyzed by ESI-MS, a resource unavailable at
the time of reaction product collection.
The last DNA model used to study the interaction between these Ru compounds
was an l l-rner DNA sequence, and both single strands as well as a duplex form were
reacted in phosphate buffered solution. This was due to the apparent significance of the
presence of phosphate which was indicated by the reaction of cis-RuCIlDMSO)4 with
dG. The cis-RuCl 2(DMSO).{ reactions were analyzed by RP-HPLC (Figure 18), and for
all of the reactions a single, identical new peak was observed, accompanied by a
broadening of the DNA peak . The control DNA reactions showed no peak. broadening.
The control Ru reaction in phosphate buffer gave a single peak identical to that of the
reactions. The mass spectrum for this new peak was attributed to an interaction between
Ru and phosphate which was most likely RU2PO.{(DMSO)6(H20)X with x equal to I or 2
(Figure 19). The mass spectrum for the broadened l l-rner peaks showed only
unmodified DNA (Figure 20). Although

DO

RulDNA interaction was seen for these

reactions, the formation of the proposed phosphate Ru dimer may in part explain the
lower in vivo activity of cis-RuCl 2(DMSO).{ compared to lrans-RuCI 2(DMSO)4' If this
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dirner is in part formed within cells it would reduce the amount of Ru available to interact
with DNA.
Similar Ll-mer reactions were also performed with

tran.s~RuCI'2(DMSO)4

in

phosphate buffer. RP HPLC. which had been used. to monitor reactions up to this point.
was abandoned for these reactions due to the unexplained disappearance of all DNA
peaks. Instead these reactions were monitored using SE HPLC, and again all of the
reactions containing Ru showed a broadening of the DNA peaks not observed in the
control DNA reactions (Figure 21). This broadening was in the direction of shorter
retention time only. This suggests that perhaps Ru had bound to the DNA strands and had
modified the structure causing an increase in the effective size of the DNA. Any
modified DNA structure with an increase in the effective size should have a shorter
retention time on the size exclusion column. This may be due to interstrand crosslinking
or the binding of many Ru compounds La a single DNA strand. No peaks were seen for
the cono:ollrans-RuCl'2(DMSO)4 reaction in phosphate buffer by either HPLC method
(Figure 22). From this it can be deduced that the dimerization proposed for cis
RuCl 2(DMSO)4 is not duplicated by trans-RuCliDMSO)4' or at least not in any
comparable amount. These reactions could not be analyzed further because an
incompatibility between the SE buffer and the ESJ-MS spray needle.
Of particular interest for any future work on this project would be to repeat the
l l-rner reactions with trans-RuC!2(DMSO)4 using a volatile SE buffer such as NH 40Ac
so that samples could be analyzed using ESI-MS. This may allow for the
characterization of the RulDNA interaction responsible for increasing the effective size
of

me

l l-rner DNA on the SE HPLC column: A more detailed look at the solution
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chemistry of rrans-RuCl lDMSO)4, perhaps as a function of time, might also provide a
better understanding for the appearance of unpredicted species in the solution.
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Conclusion

The agreement of NMR, CHN, and UV-Vis data with previously reported data
and theoretical results indicates the successful synthesis of both cis and trans
RuCI 2(DMSO)~ .

The cis-RuCI 2(DMSO)4 may be somewhat contaminated with another

Ru-DMSO compound judging from the impurity peaks in the IH NMR spectrum. Further
washes and recrystallizations may yield more pure crystals, but the current condition of
ClS-RuC1lDMSO).1 seems good enough for DNA-binding reactions. The trans
RuCl2(DMSO)~ product appears to be very pure. CHN data was nearly identical and

lH

and 13C NMR spectra showed no impurity.
The kinetics of lrans-RuCliDMSO)~binding to DNA was shown to be much
faster than that of cis-Ru02(DMSO)~as had been previously shown in similar studies.
The precipitation problems which occurred during these reactions inhibited any specific
study of the nature of the RulDNA interaction. The enzymatic digestions of certain
timepoints did indicate that any Ru-DNA binding may be reversible. This was also
indicated by the reactions with nucleosides, in particular with cis-RuCI 2(DMSO)4 and dG
in phosphate buffer. All nucleoside reactions showed some indication of a RuJDNA
interaction, but no product was isolated and then further identified.
The solution chemistry, previously reponed to be well understood for both cis and
lrans-RuC1iDMSO)4, was examined using ESI -MS . The species present in the spectrum
for cis-RuCI 2(DMSO)4 were in accordance with the reported order of ligand loss, while
the spectrum for

lrans-RuCl2(DMSO)~

showed some discrepancy with the literature.

Multiple peaks were identified and attributed 'to species which would not be present in the
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currently proposed order of ligand loss. Perhaps the solution chemistry of this molecule
is not locked into the single, currently proposed order of ligand dissociation.
The It-mer reactions provided more information than any others. For reactions
with cis-RuCl 2(DMSO)4' products containing only Ru and not DNA were formed in the
presence of phosphate buffer. Evidence indicates that this may be the Ru/Pi dirner
Ru 2P04(DMSOMH20)x with x. equal to 1 or 2 (or more). No significant Ru interaction
was seen for controls with rrans-RuCl 2(DMSO)J suggesting that only cis-RuCllDMSO)4
forms such a dimer. If dimer formation occurs in vivo it may help explain the lower
antitumor activity of this isomer. The broadening of DNA peaks in both of these
reactions, and in particular with rrans-RuCI 2(DMSO)4, indicate some RulDNA interaction
is occurring. There was no conclusive evidence of this because ESI-MS data showed no
such interactions for the samples that could be injected into the instrument.
Any future work on this project should involve reactions in a volatile buffer such
as NHJOAc and of particular interest would be the reactions of rrans-RuC1 2(DMSO)J
with the 1l-rner. The nucleoside reactions may also provide Ru-bound DNA if samples
are injected into the ESI-MS immediately following collection. CT-DNA reactions with
a lower R, may inhibit DNA precipitation, and allow for further study. Another
experiment would be to synthesize the proposed RulPi dimer on a larger scale for further
characterization by

J1p

NMR and single crystal X-ray diffraction.
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Appendix
Table 1- HPLC gradients used for reaction analysis and product collection

Grad ient 1ln ucleosideJenzvme diaestion analvsls)
%A
%B
Time
flow
curve
*
I
1.0
100
0

10
20
22
24
34

1.0
1.0
1.0
1.0
1.0

75
50
0
100
100

25
50
100
0
0

6
6
6
6
6

Gradient 2f11-mer reaction analvsls)
%A
%8
curve
Time
flow

I

20
25
30
32
42

1.0
1.0
1.0
1.0
1.0
1.0

100
50
0
0
100
100

0
50
100
100
0
0

*

6
6
6
6
6

41

Table 2- Comparison of experimental CRN data versus theoretical values

CHN Data

cis -RuCb(DMSO)4
Theory
Exp.

C 19.830/0 H 4.990/0
C 19.610/0 H 4.960/0

cis -RuCb(DMSO)4
Theory
Exp.

1st reaction

2nd reaction

C 19.830/0 H 4.990/0
C 19.310/0 H 4.930/0

trans -RuCb(DMSO)4
Theory
Exp.

C 19.830/0 H 4.990/0
C 19.830/0 H 4.930/0

42

Table 3- The ICP data for the control reaction containing only cis-RuCIlDMSO)4
and no DNA. Precipitation left less than 0.1 % of the original Ru in solution.

Time(hr)

0
3
6
24
27
30

Initial

Ru(~g)

145.6
145.6
145.6
145.6
145.6
145.6

Timepoint

Ru(~g)

0.0836
0.0298
0.0408
0.0022
0.0368
0.0105

0/0 Ru remaining
0.0574
0.0205
0.0280
0.0015
0.0253
0.0072
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Table 4· rcp data for the timepoints collected from the reaction of both cis and
trans-RuCI 2(DMSO)4 with CT DNA.

Reaction

Timepoint

~g Ru

H2O

-

0.0199

cis -RuCI 2(DMSO)4 only

-

0.0101

trans -RuCI 2(DMSO)4 only

-

0.0193

trans -RuCI 2(DMSO)4 + CT DNA

0

0.0440

cis -RuCI 2(DMSO)4 + CT DNA

0

0.0152

cis- RuCI2(DMSO)4 + CT DNA

1 Day

0.0790

cis -RuCI 2(DMSO)4 + CT DNA

9 Days

0.1590
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DMSO'/J,•.

r

.>,\\\DMSO

DMSo'''''''''~DMSO

Fast

CI

DMSO"J,.

r

>,\\\01-1 2

DMSO~'~ClH,

slow

CI

Trans-RuCliDMSO)~

slow

Fast

cis-RuCI2(DMSO)~

Figure 4- The behavior of cis and trans-RuC1lDMSO)4 in aqueous solution.
For each compound the rapid loss of one or two DMSO groups is followed by
a slower loss of a single chloride. For cis-RuC1lDMSO)4 the oxygen bound
DMSO is the one group lost, while trans-RuCIlDMSO)4 loses two sulfur
bound DMSO groups.
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45

(2)

(1)

Figure 5- The proposed interactions of phosphate buffer with (1) cis-RuCliDMSO)4
and (2) trans-RuCI 2(DMSO)4'
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Figure 6- IH NMR of cis-RuCIlDMSO)4 in deuterated DMSO. The
quintet at 2.5 ppm is attributed to the DMSO solvent. The peaks at 2.6 and
2.7 ppm are caused by free and oxygen bound DMSO respectively. The
grouping of four peaks between 3.2 and 3.5 ppm are caused by different
types of sulfur bound DMSO. Data is consistent with NMR data reported in
"
16
Iiterarure.
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Figure 7- IH NMR in CDCl) of the product from the second synthesis of
cis-RuCliDMSO)4' The change in solvents makes the peaks from free and
oxygen bound DMSO at 2.6 and 2.7 ppm more visible. Again there is a
group of peaks due to sulfur bound DMSO between 3.2 and 3.5 ppm. This
product appears to contain some impurities seen from 1.2 to 2.2 ppm. The
peak at 7.27 is attributed to chloroform.
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Figure 8- lH NMR of photoreacted product in CDCl) showing signals
at 2.62 and 3.38 ppm. These peaks are caused by free and oxygen
bound DMSO respectively. Literature gives signals at 2.62 and 3.41
ppm. The downfield peak at 7.27 ppm is attributed to chloroform.
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Figure 9- Th e experimental photoreaction from cis to ,ruJ/s-R uCI2(DMSO t
mo ni tored by UV-Vis ompared to the literatur equivalent for the th rrnal
conversio n

or tran.

to c;s-R uC I2(DMSO t .

50

J

1

j

iii I iIi iii

7

"' i i i Iii

6

iii iii i

J iii

5

iii iii

I iii

4

Iii iii Iii

3

iii iii iii

2

iii iii iii iiI iii iii Iii

1

Figure 10- IH NMR for second photoreacted product in CDC13 again
showing signals at 2.62 and 3.38 ppm. The downfield peak at 7.27 ppm
is attributed to chloroform.
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Figure 11- 13C NMR of trans-RuC12(DMSO)4 in deuterated
chloroform. Previous reports (Alessio) gave peaks at 42.78 and 41.14
ppm The two experimental peaks seen are at 43.02 and 41.41 ppm. The
triplet at 77 ppm is attributed to chloroform,
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de

T

dG

dA

Control Digestion

New peak

New peak

\
CisT=!

TransT=O

Figure 13a- RP HPLC traces of timepoint digestions show a single,
identical peak in each reaction not present in the control digestion

Cis T=l

Trans T=O

Figure 13b- RP HPLC traces of large scale digestions of the same
timepoints three months later showing the disappearance of the
previously seen peak.
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de

Unreacred dG Standard

200 J.lM dG reaction

400 jlM dG reaction

T

dG

dA

Unreacted Mix Standard

200 llM Mix reaction

400 jlM Mix reacuon

Figure 14- RP HPLC traces of reactions between trans
RuC1zCDMSO)4 and dG or a nucleoside mix. Reactions with higher
[DNA] have more product-peak intensity suggesting faster kinetics.
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Reactions with nucleosides and Ru

Control dG

Activated cis-RuCI 1(DMSO), with M1X

Activated cis -RuCllDMSO). with dG

j~k

Activated trans-RuCl,(DMSO), with Mix

Activated trans -RuC1lDMSO), with dG

Fresh cis-RuC1lDMSO), with Mix

Fresh cis· RuCl, (DMSO}, wilh dG

Fresh lrlJllS-RuCll(DMSO), with Mix

Fresh lrans -RuC!,(DMSO), with dG

Controls with Ru compounds

I

Activated cis -RuC11(DMSO),

~"-------

I

Activated tran.r-RuCI1(DMSO},

I

Fresh cis-RuCll(DMSO},

I

Fresh trans-RuCllDMSO),

Figure 15- RP HPCL traces for reactions with fresh and activated Ru
compounds with nucleosides compared to controls.
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(2)

(1)

Fast

OMSOI1"

•

r,:,\C'

oMso':T" CI

(3)

OMS0111,.
slow

r,~\,\OH2

OMS0 ' : '' "CI
OMSO

OMSO

cis·RuCI,JDMSO).,

371 .3

.6

(1)- CI
309.3

(2)

2G5.3

m/z

Figure 16a- Mass spectrum of cis-RuCliDMSO)4 in solution. (1) is not
seen in the spectrum in agreement with the rapid loss of a DMSO ligand in
solution. (1) minus a chlorine was not observed in similar studies reported in
literature but appears here. Both (2) and (3) are present as well as other peaks
associated with the loss of additional ligands. The loss of water was most
probably caused during ionization in the spray source.
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(4)

(6)

(5)

DMSO"" •. r.\\\\\DMSO

DMSO"1'DMSO

r
DMSO"";,.~OH,
DMSO"II.

Fast

CI

DMSO"" ..

,\\\\OH 2

slow

r\~\\\OH2

DMSO"T~OH2
CI

CI

trans-RuCI,(DMSO)..

(3) - H:P
:510.3

371.3

(4)- 2CI
293.4

0.0_....-...............
280

(6)

-433.3

(4)- Cl

413.3

300

Figure 16b- Mass spectrum of trans-RuCI2(DMSO)4 in solution. (4) is not
seen in the spectrum in agreement with the rapid loss of ligands in solution.
(5) is also not seen but (3), the reported component of cis-RuCliDMSO)4 in
solution is present here. The presence of (3) as well as (4)-XCI(X:::l,2) may
indicate that the solution chemistry of trans-RuC1 2(DMSO)4 is not a fixed
order of ligand loss. The presence of (6) and many of water deficient isomers
of (6) suggests that ligand loss ends at (6), but perhaps there is more than one
order for ligand loss, all ending there.
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Control dG Standard

Unreacted

dG

AB

cis-RuCllDMSO). reacted with dG in Pi buffer

Figure 17a- The reaction of cis-RuCliDMSO)4 with dG in phosphate
buffer. New peaks were collected, stored in freezer for ESI-MS and later
rerun by RP HPLC.
dG

I A,B

rerun weeks later under same HPLC conditions

Figure 17b- The collected peaks were rerun on the RP HPLC. Peaks
A,B were collected together and by the time they were rerun, they gave
back dG only.
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Duplex Control

Strand I CODtrO[

Duplex + cis-RuCI 2(DMSO),

SLTaDd J + ds-RuCll(DMSO).

Strand 2 Control

Figure 18- RP HPLC traces for reactions between l I-mer and cis
RuC1iDMSO)4"
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802.8

784 .9

Ru2PO lDMSOMH,O),
[M+IH]1o

(1)

Ru2PO.(DMSO)6(HP)
[M+JHr·

(2)

Figure 19- Experimental mass spectrum from the new peaks seen in
reactions of l l-mer strands and cis-RuCliDMSO)4-(1) and and from the
contro1 reaction of cis-RuCliDMSO)4 in phosphate buffer alone(2). The
proposed structure accountable for (2) is the same as (1) missing one of
the coordinated water ligands, which was most likely lost during
ionization in the ESI spray source . Conditions in the spray source varied
daily due to the different spray needles which were used when clogging
occurred.
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Strand 2
[M-3Hl ~

Strand)
[M-3H] '"

Strand 2
[M-4H]'"

mlz

(1)

Strand 2
[M-3H] l-

Strand 2

[M-4H]'

mlz

(2)

Figure 20- The mass spectrum of the control duplex reaction gives clear
peaks for strands 1 and 2 (1). The mas spectrum for the broadened duplex
peak (2) in reactions with cis-RuCliDMSO)4 gives only clear peaks for
unmodified strand 2, but no conclusive ev idence that strand 1 has Ru
bound.
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Duplex

Strand I CoolIol

Strand 2 Control

Duplex + rrans-RuCll(DMSO),

Strand I + Irans -RuCliDMSO),

Strand 2 + /rluu-RuCI/DMSO),

Figure 21- SE HPLC traces from l l-mer reactions with trans
RuCIlDMSO)4"
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Trans-RuCllDMSO). in phosphate buffer by RP HPLC

Trans-RuCl l(DMSO), in phosphate buffer by SE HPLC

Figure 22- The control reaction of trans-RuC1iDMSO)4 in phosphate buffer
with no DNA. Both RP and SE HPLC methods showed no evidence of dimer
formation.

